Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

Cited by (1,002)

Items 201–300 of 1,002

1. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy
   Ana Montalban‐Arques, Michael M. Scharl · 2019 · EBioMedicine
2. Dysbiosis of Oral Microbiota During Oral Squamous Cell Carcinoma Development
   Purandar Sarkar, Samaresh Malik, Sayantan Laha, Shantanab Das, Soumya Bunk, Jay Gopal Ray, Raghunath Chatterjee, Abhik Saha · 2021 · Frontiers in Oncology
3. Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis
   Gang Chen, Chunna Gao, Shan Jiang, Cai Qiaoling, Rongrong Li, Qiang Sun, Can Xiao, Yubo Xu, Buling Wu, Hongwei Zhou · 2023 · Journal of Advanced Research
4. Pretreatment with probiotic Bifico ameliorates colitis‐associated cancer in mice: Transcriptome and gut flora profiling
   Huan Song, Weiyi Wang, Bo Shen, Hao Jia, Zhaoyuan Hou, Ping Chen, Yunwei Sun · 2017 · Cancer Science
5. MicroRNAs at the Host–Bacteria Interface: Host Defense or Bacterial Offense
   Carmen Aguilar, Miguel Mano, Ana Eulálio · 2018 · Trends in Microbiology
6. Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway
   Le Liu, Liping Liang, Huifen Liang, Mingming Wang, Bingyun Lu, Meng Xue, Jun Deng, Ye Chen · 2019 · Frontiers in Immunology
7. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer
   Lidia Sánchez‐Alcoholado, Rafael Ordóñez, Ana Pardessus Otero, Isaac J. Plaza-Andrades, Aurora Laborda-Illanes, José Antonio Medina, Bruno Ramos‐Molina, Jaime Gómez‐Millán, María Isabel Queipo‐Ortuño · 2020 · International Journal of Molecular Sciences
8. F. nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production
   Jiwei Sun, Qingming Tang, Shaoling Yu, Mengru Xie, Wenhao Zheng, Guangjin Chen, Ying Yin, Xiaofei Huang, Keqi Wo, Haoqi Lei et al. · 2023 · EBioMedicine
9. Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum
   Liang Wang, Chun‐Han Lo, Xiaosheng He, Dong Hang, Molin Wang, Kana Wu, Andrew Tan Chan, Shuji Ogino, Edward L. Giovannucci, Mingyang Song · 2020 · Gastroenterology
10. Toll-like receptor 4: A potential therapeutic target for multiple human diseases
    Jinrui Wei, Yan Zhang, Haopeng Li, Fuquan Wang, Shanglong Yao · 2023 · Biomedicine & Pharmacotherapy
11. Comparison of microbiota in patients treated by surgery or chemotherapy by 16S rRNA sequencing reveals potential biomarkers for colorectal cancer therapy
    Deng, Xingming, Li, Zhuofei, Li, Guan, Li, Bei, Jin, Xinhan, Lyu, Guoqing · 2018 · Frontiers in Microbiology
12. The gut microbiome and cancer: from tumorigenesis to therapy
    Amandine Nobels, Cédric van Marcke, Bénédicte F. Jordan, Matthias Van Hul, Patrice D. Cani · 2025 · Nature Metabolism
13. YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation
    Hua Xiu Sui, Lu Zhang, Kaijuan Gu, Ni Chai, Qing Ji, Lihong Zhou, Yan Wang, J. Ren, Limei Yang, Bimeng Zhang et al. · 2020 · Cell Communication and Signaling
14. Fusobacteria modulate oral carcinogenesis and promote cancer progression
    Amani M. Harrandah, Sasanka S. Chukkapalli, Indraneel Bhattacharyya, Ann Progulske‐Fox, Edward K. L. Chan · 2020 · Journal of Oral Microbiology
15. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm
    Longsha Liu, Khalid Shah · 2022 · JAMA Oncology
16. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing
    Francesco Prattichizzo, Angelica Giuliani, Emanuela Mensa’, Jacopo Sabbatinelli, Valeria De Nigris, Maria Rita Rippo, Lucia La Sala, Antonio Domenico Procopio, Fabiola Olivieri, Antonio Ceriello · 2018 · Ageing Research Reviews
17. Enterobacterial LPS-inducible LINC00152 is regulated by histone lactylation and promotes cancer cells invasion and migration
    Jianwei Wang, Zhi Liu, Yuyu Xu, Yipeng Wang, Fei Wang, Qingqing Zhang, Chunhua Ni, Zhen Yi, Rui Cheng Xu, Qisha Liu et al. · 2022 · Frontiers in Cellular and Infection Microbiology
18. Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
    Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang, Guanhua Du · 2021 · Cancer Biology and Medicine
19. Intracellular bacteria in cancer—prospects and debates
    Lena Schorr, Marius Mathies, Eran Elinav, Jens Puschhof · 2023 · npj Biofilms and Microbiomes
20. Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis
    Marcela Alcântara Proença, Joice Matos Biselli, Maysa Succi, Fábio Eduardo Severino, Gustavo Nóriz Berardinelli, Alaor Caetano, Rui Manuel Reis, David J. Hughes, Ana Elizabete Silva · 2018 · World Journal of Gastroenterology
21. Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice
    Bolei Li, Ge Yang, Lei Cheng, Benhua Zeng, Jinzhao Yu, Xian Peng, Jianhua Zhao, Wenxia Li, Biao Ren, Mingyun Li et al. · 2019 · International Journal of Oral Science
22. Parkin and Nrf2 prevent oxidative stress-induced apoptosis in intervertebral endplate chondrocytes via inducing mitophagy and anti-oxidant defenses
    Liang Kang, Shiwei Liu, Jingchao Li, Yueyang Tian, Yuan Xue, Xiaozhi Liu · 2019 · Life Sciences
23. Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
    Jiaao Sun, Feng Chen, Guangzhen Wu · 2023 · The ISME Journal
24. LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells
    Xinke Wang, Zhixian Lan, Juan He, Qiuhua Lai, Xiang Yao, Qingyuan Li, Yongfeng Liu, Huasheng Lai, Chun-Cai Gu, Qun Yan et al. · 2019 · Cancer Cell International
25. The roles of the gut microbiota–miRNA interaction in the host pathophysiology
    Meihong Li, Weidong Chen, Yan‐Dong Wang · 2020 · Molecular Medicine
26. Dissecting miRNA signature in colorectal cancer progression and metastasis
    Xiangjie Huang, Xinping Zhu, Yun Yu, Wangyu Zhu, Libo Jin, Xiaodong Zhang, Shaotang Li, Peng Zou, Congying Xie, Ri Cui · 2020 · Cancer Letters
27. Customized materials-assisted microorganisms in tumor therapeutics
    Qi‐Wen Chen, Jiyan Qiao, Xinhua Liu, Cheng Zhang, Xian‐Zheng Zhang · 2021 · Chemical Society Reviews
28. Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
    Xuebing Yan, Liguo Liu, Hao Li, Huanlong Qin, Zhenliang Sun · 2017 · OncoTargets and Therapy
29. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of Fusobacterium nucleatum in Colorectal Cancer
    Xin Zheng, Rui Liu, Chenchen Zhou, Haopeng Yu, Wanyi Luo, Jianhui Zhu, Jiaxin Liu, Zhe Zhang, Na Xie, Xian Peng et al. · 2021 · Cancer Research
30. The role of Wnt signaling pathway in tumor metabolic reprogramming
    Yongzhen Mo, Yumin Wang, Lishen Zhang, Liting Yang, Ming Zhou, Xiaoling Li, Yong Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong et al. · 2019 · Journal of Cancer
31. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing
    Tianyu Liu, Xueli Song, Samiullah Khan, Yun Li, Zixuan Guo, Chuqiao Li, Sinan Wang, Wenxiao Dong, Wentian Liu, Bangmao Wang et al. · 2019 · International Journal of Cancer
32. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion
    Tianhao Zhang, Ying Li, Ertao Zhai, Risheng Zhao, Yan Qian, Zhixin Huang, Yinan Liu, Zeyu Zhao, Xiang Xu, Jianqiu Liu et al. · 2025 · Cancer Research
33. The role of autophagy in maintaining intestinal mucosal barrier
    Yanping Wu, Li Tang, Baikui Wang, Qiming Sun, Pengwei Zhao, Weifen Li · 2019 · Journal of Cellular Physiology
34. Eating microRNAs: pharmacological opportunities for cross‐kingdom regulation and implications in host gene and gut microbiota modulation
    Lorena del Pozo‐Acebo, María‐Carmen López de las Hazas, Abelardo Margollés, Alberto Dávalos, Almudena García‐Ruiz · 2021 · British Journal of Pharmacology
35. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
    Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone · 2022 · Cancers
36. Gut microbiota as important modulator of metabolism in health and disease
    Xiang‐qian Wang, Aihua Zhang, Jian-hua Miao, Hui Juan Sun, Guangli Yan, Fangfang Wu, Xi-jun Wang · 2018 · RSC Advances
37. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy
    Vrishketan Sethi, Gerardo A. Vitiello, Deepak B. Saxena, George Miller, Vikas Dudeja · 2019 · Gastroenterology
38. Urea cycle activation triggered by host-microbiota maladaptation driving colorectal tumorigenesis
    Haoyan Chen, Tianying Tong, Shiyuan Lu, Linhua Ji, Baoqin Xuan, Gang Zhao, Yuqing Yan, Linhong Song, Licong Zhao, Yile Xie et al. · 2023 · Cell Metabolism
39. Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer
    Dmitri Mouradov, Paul A. Greenfield, Shan Li, Eun-Jung In, Claire Storey, Anuratha Sakthianandeswaren, Peter Georgeson, Daniel D. Buchanan, Robyn Lynne Ward, Nicholas John Hawkins et al. · 2023 · Gastroenterology
40. Clinical applications of gut microbiota in cancer biology
    Sunny Hei Wong, Thomas N.Y. Kwong, Chun‐Ying Wu, Jun Qing Yu · 2018 · Seminars in Cancer Biology
41. Intestinal microbiota, chronic inflammation, and colorectal cancer
    Chan Hyuk Park, Chang Soo Eun, Dong Soo Han · 2018 · Intestinal Research
42. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer
    Junfeng Sun, Haowei Jia, Xingqi Bao, Yue Wu, Tianyu Zhu, Ruixin Li, Hongchao Zhao · 2021 · Cell Death and Disease
43. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
    Hui Xu, Chenxi Cao, Yuqing Ren, Siyuan Weng, Long Liu, Chunguang Guo, Libo Wang, Xinwei Han, Jianzhuang Ren, Zaoqu Liu · 2022 · Frontiers in Immunology
44. Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2/STAT3/GPX4 axis
    Jianqin Lai, Lele Zhao, Chao Hong, Qiu-ming Zou, Jin-xuan Su, Sijia Li, Xiaofeng Zhou, Zisheng Li, Bo Deng, Jie Cao et al. · 2024 · Acta Pharmacologica Sinica
45. Fusobacterium nucleatum facilitates ulcerative colitis through activating IL‐17F signaling to NF‐κB via the upregulation of CARD3 expression
    Yongyu Chen, Yan Chen, Pan Cao, Wenhao Su, Na Zhan, Weiguo Dong · 2019 · The Journal of Pathology
46. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
    Aneta Ševčíková, Nikola Izoldova, Viola Števurková, Barbora Kasperova, Michal Chovanec, Soňa Čierniková, Michal Mego · 2022 · International Journal of Molecular Sciences
47. FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer
    Chunjie Xu, Lei Gu, Li-Peng Hu, Chunhui Jiang, Qing Li, Longci Sun, Hong Zhou, Ye Liu, Hanbing Xue, Jun Li et al. · 2023 · Nature Communications
48. Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors
    Zhifen Cui, Yu Zhang, Kai Xia, Qinglong Yan, Huating Kong, Jichao Zhang, Xiaolei Zuo, Jiye Shi, Lihua Wang, Ying Jie Zhu et al. · 2018 · Nature Communications
49. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms
    Tsuyoshi Hamada, Jonathan Andrew Nowak, Danny A. Milner, Mingyang Song, Shuji Ogino · 2019 · The Journal of Pathology
50. The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
    Luca Mazzarella, Bruno Achutti Duso, Dario Trapani, Carmen Belli, Paolo D’Amico, Emanuela Ferraro, Giulia Viale, Giuseppe Curigliano · 2019 · European Journal of Cancer
51. The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites
    Yongqiang Liu, Cheng Kong, Li Gong, Xiaohui Zhang, Yuefei Zhu, Haichao Wang, Xiao Qu, Renyuan Gao, Fang Yin, Xueyuan Liu et al. · 2020 · Journal of Alzheimer s Disease
52. The role of gut microbiota and metabolites in cancer chemotherapy
    Shiyu Li, Shuangli Zhu, Jun Yu · 2023 · Journal of Advanced Research
53. Biological biomarkers of oral cancer
    Allan Radaic, Pachiyappan Kamarajan, Alex Cho, Sandy Wang, Guo‐Chin Hung, Fereshteh Najarzadegan, David T. Wong, Hung Ton‐That, Cun‐Yu Wang, Yvonne Lorraine Kapila · 2023 · Periodontology 2000
54. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps
    Siyuan Liang, Yan Kai Mao, Ming Liao, Yansong Xu, Ying-Chun Chen, Xiaoliang Huang, Chuangyi Wei, Changtao Wu, Qiuyan Wang, Xiaoyan Pan et al. · 2019 · International Journal of Biological Sciences
55. Synergistic Target of Intratumoral Microbiome and Tumor by Metronidazole–Fluorouridine Nanoparticles
    Chunxiao Gao, Xijun Wang, Bing Yang, Wei Yuan, Wei Huang, Guoju Wu, Jie Ma · 2023 · ACS Nano
56. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer
    Dae‐Won Lee, Sae‐Won Han, Jun‐Kyu Kang, Jeong Mo Bae, Hwang‐Phill Kim, Jae‐Kyung Won, Seung‐Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Tae‐You Kim · 2018 · Annals of Surgical Oncology
57. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence
    Marco Vacante, Roberto Ciuni, Francesco Basile, Antonio Biondi · 2020 · Biomedicines
58. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review
    Maryam Ranjbar, Rasoul Salehi, Shaghayegh Haghjooy Javanmard, Laleh Rafiee, Habibollah Faraji, Sima jafarpor, Gordon A. Ferns, Majid Ghayour‐Mobarhan, Mostafa Manian, Reza Nedaeinia · 2021 · Cancer Cell International
59. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer
    Bowen Li, Zixian Wei, Zhiyue Wang, Fangqi Xu, Jinhua Yang, Baiqiang Lin, Yu Chen, Hubin Wenren, Lingli Wu, Xiao Guo et al. · 2024 · Free Radical Biology and Medicine
60. Promising dawn in tumor microenvironment therapy: engineering oral bacteria
    Wang, Zifei, Sun, Wansu, Hua, Ruixue, Wang, Yuanyin, Li, Yang, Zhang, Hengguo · 2024 · International Journal of Oral Science
61. Neoadjuvant treatment of colorectal cancer: comprehensive review
    Henry George Smith, Per Johan Nilsson, Benjamin D. Shogan, Deena Pravin Harji, Maria Antonietta Gambacorta, Ângela Romano, Andreas Brandl, Camilla Qvortrup · 2024 · BJS Open
62. Microbiota-driven mechanisms at different stages of cancer development
    Elena Ivleva, Sergei I. Grivennikov · 2022 · Neoplasia
63. Gut virome in inflammatory bowel disease and beyond
    Hein M. Tun, Ye Peng, Luca Massimino, Zhen Ye Sin, Tommaso Lorenzo Parigi, Amanda Facoetti, Shaila Rahman, Silvio Danese, Federica Ungaro · 2023 · Gut
64. The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance
    Nilmara de Oliveira Alves, Guillaume Dalmasso, Darja Nikitina, Amaury Vaysse, Richard Ruez, Léa Ledoux, Thierry Pédron, Emma Bergsten, Olivier Boulard, Lora Autier et al. · 2024 · Gut Microbes
65. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis
    Lu Zhang, Xiao-Xu Leng, Jianxun Qi, Ni Wang, Ji‐Xuan Han, Zhi‐Hang Tao, Zi-Yan Zhuang, Yimeng Ren, Yile Xie, Shanshan Jiang et al. · 2024 · Nature Microbiology
66. Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages
    Xue Ying, Xiao Han, Songhe Guo, Banglao Xu, Yuehua Liao, Yixian Wu, Ge Zhang · 2018 · Cell Death and Disease
67. Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models
    Jiali Dong, Yuan Li, Huiwen Xiao, Shuqin Zhang, Bin Wang, Haichao Wang, Yiliang Li, Saijun Fan, Ming Cui · 2021 · Cell Reports
68. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment
    Yali Liu, Harry Cheuk-Hay Lau, Wing Yin Cheng, Jun Qing Yu · 2022 · Genomics Proteomics & Bioinformatics
69. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway
    Jianwei Zhang, Dan Zhang, Haisen Yin, Han Zhang, Kunqiao Hong, Jingping Yuan, Baoping Yu · 2023 · Gut Microbes
70. Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota
    Floriana Morgillo, Marcello Dallio, Carminia Maria Della Corte, Antonietta Gerarda Gravina, Giuseppe Viscardi, C. Loguercio, Fortunato Ciardiello, Alessandro Federico · 2018 · Neoplasia
71. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in ApcMin/+ Mice
    Cécily Lucas, Laurène Salesse, My Hanh Thi Hoang, Mathilde Bonnet, Pierre Sauvanet, Anaïs B. Larabi, Catherine Godfraind, Johan Gagnière, Denis Pezet, Philip C Rosenstiel et al. · 2020 · Gastroenterology
72. Carcinogenic microbiota and its role in colorectal cancer development
    Tomasz M. M Karpiński, Marcin Ożarowski, Mark Stasiewicz · 2022 · Seminars in Cancer Biology
73. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis
    Goodwin G. Jinesh, Andrew Scott Brohl · 2022 · Signal Transduction and Targeted Therapy
74. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
    Wei Ping Jia, Cynthia Rajani, Hong‐Xi Xu, Xiaojiao Zheng · 2020 · Protein & Cell
75. Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
    Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, Tomotaka Ugai, Shinichi Yachida, Shuji Ogino · 2022 · Gut
76. Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts
    Xiaowen Huang, Muni Hu, Tiantian Sun, Jiantao Li, Yilu Zhou, Yuqing Yan, Baoqin Xuan, Jilin Wang, Hua Xiong, Linhua Ji et al. · 2023 · Cell Host & Microbe
77. Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis
    Luping Chen, Linfang Zhang, Hua Hua, Li Liu, Yuejian Mao, Ruirui Wang · 2024 · Immunity Inflammation and Disease
78. Sarcoidosis and the mTOR, Rac1, and Autophagy Triad
    Y. Pachéco, Clarice X. Lim, Thomas Weichhart, Dominique Valeyre, Abderrazzak Bentaher, Alain Calender · 2020 · Trends in Immunology
79. Effects of microbiota on anticancer drugs: Current knowledge and potential applications
    Jiayuan Huang, Wenting Liu, Wanying Kang, Yulong He, Ruifu Yang, Xiangyu Mou, Wenjing Zhao · 2022 · EBioMedicine
80. The human microbiome and cancer: a diagnostic and therapeutic perspective
    Shruthi Kandalai, Huapeng Li, Nan Zhang, Haidong Peng, Qingfei Zheng · 2023 · Cancer Biology & Therapy
81. Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury
    Xiao Qu, Fang Yin, Manman Pei, Qian Chen, Yuanyuan Zhang, Shengwei Lu, Xuelian Zhang, Ziyuan Liu, Xinyao Li, Hangrong Chen et al. · 2023 · ACS Nano
82. Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
    Zhumin Cao, Ke Tian, Yincheng Ran, Haonan Zhou, Lei Zhou, Yana Ding, Xiaowei Tang · 2024 · Frontiers in Immunology
83. Gut microbiome: a new player in gastrointestinal disease
    Gregor Gorkiewicz, Alexander Rupert Moschen · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
84. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15
    Huiyuan Zhu, Man Li, Dexi Bi, Huiqiong Yang, Yaohui Gao, Feifei Song, Jiayi Zheng, Ruting Xie, Youhua Zhang, Hu Liu et al. · 2024 · Nature Communications
85. Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer
    Azucena Ramos, Michael T. Hemann · 2017 · Cell
86. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes
    Federica Perillo, Chiara Amoroso, Francesco Strati, Maria Rita Giuffrè, Angélica Díaz‐Basabe, Georgia Lattanzi, Federica Facciotti · 2020 · International Journal of Molecular Sciences
87. Fusobacterium nucleatum Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT
    Mi Ra Yu, Hye Jung Kim, Hae Ryoun Park · 2020 · Cancers
88. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers
    Karolina Kaźmierczak-Siedlecka, Giandomenico Roviello, Martina Catalano, Karol Połom · 2021 · Nutrients
89. Crosstalk between gut microbiota and host immune system and its response to traumatic injury
    Hanif Ullah, Safia Arbab, Yali Tian, Yuwen Chen, Changqing Liu, Qijie Li, Ka Li · 2024 · Frontiers in Immunology
90. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
    Guolong Xu, Dongju Feng, Yao Yao, Peipei Li, Hua Sun, Hong Yang, Changxian Li, R Jiang, Beicheng Sun, Yun Chen · 2019 · Oncogene
91. Dissecting the Interplay Mechanism between Epigenetics and Gut Microbiota: Health Maintenance and Disease Prevention
    Yuqi Wu, Chong‐Zhi Wang, Jin‐Yi Wan, Haiqiang Yao, Chun‐Su Yuan · 2021 · International Journal of Molecular Sciences
92. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Annemieke Smet, Juozas Kupčinskas, Alexander Link, Georgina Louise Hold, Jan Bornschein · 2021 · Cellular and Molecular Gastroenterology and Hepatology
93. Tumor microbiome – an integral part of the tumor microenvironment
    Soňa Čierniková, Aneta Ševčíková, Viola Števurková, Michal Mego · 2022 · Frontiers in Oncology
94. The Contribution of the Human Oral Microbiome to Oral Disease: A Review
    Austin Gregory Morrison, Soumyadev Sarkar, Shahid Umar, Sonny T. M. Lee, Sufi Mary Thomas · 2023 · Microorganisms
95. The microbiome in cancer
    Anqi Lin, Minying Xiong, Aimin Jiang, Li‐Hua Huang, Hank Z. H. Wong, Suyin Feng, Chunyan Zhang, Haijun Yu, Li Chen, Hao Chi et al. · 2025 · iMeta
96. Bile Acids, Their Receptors, and the Gut Microbiota
    James C. Poland, Charles Robb Flynn · 2021 · Physiology
97. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1
    Wei Ma, Lu Zhang, Weilong Chen, Zhaoxia Chang, Juchuanli Tu, Yuanyuan Qin, Yuwen Yao, Jiajun Ding, Jiajun Ding, Siqin Li et al. · 2024 · Protein & Cell
98. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum
    Caitlin A. Brennan, Geicho Nakatsu, Carey Ann Gallini, David A. Drew, Jonathan N. Glickman, Robert E. Schoen, Andrew Tan Chan, Wendy S. Garrett · 2021 · mBio
99. Tumor hijacks macrophages and microbiota through extracellular vesicles
    Jipeng Jiang, Jie Mei, Yongfu Ma, Shasha Jiang, Jian Zhang, Shaoqiong Yi, Changjiang Feng, Yang Liu, Ying Liu · 2022 · Exploration
100. MVP: a microbe–phage interaction database
     Na Gao, Chengwei Zhang, Zhanbing Zhang, Songnian Hu, Martin J. Lercher, Xing‐Ming Zhao, Peer Bork B, Zhi Liu, Wei-Hua Chen · 2017 · Nucleic Acids Research